Novel Selective PDE IV Inhibitors as Antiasthmatic Agents. Synthesis and Biological Activities of a Series of 1-Aryl-2,3-bis(hydroxymethyl)naphthalene Lignans

Journal of Medicinal Chemistry
1996.0

Abstract

A series of 1-aryl-2,3-bis(hydroxymethyl)naphthalene lignans have been synthesized and evaluated for their ability to selectively inhibit PDE IV isolated from guinea pig. Replacement of the 1-phenyl ring by a pyridone ring led to marked improvement of their selectivity for PDE IV over PDE III. The compounds that were most potent and selective involved those bearing an N-alkylpyridone ring at C-1. These compounds also showed potent antispasmogenic activity without causing significant changes in heart rate in the guinea pig. The most potent compound was 6,7-diethoxy-2, 3-bis(hydroxymethyl)-1-[1-(2-methoxyethyl)-2-oxo-pyrid-4-yl]nap hth alene (17f), ED50 values of histamine-induced and antigen-induced bronchoconstriction in the guinea pig being 0.08 and 2.3 mg/kg iv, respectively. This compound was chosen as a candidate for further pharmacological evaluation.

Knowledge Graph

Similar Paper

Novel Selective PDE IV Inhibitors as Antiasthmatic Agents. Synthesis and Biological Activities of a Series of 1-Aryl-2,3-bis(hydroxymethyl)naphthalene Lignans
Journal of Medicinal Chemistry 1996.0
Selective Type IV Phosphodiesterase Inhibitors as Antiasthmatic Agents. The Syntheses and Biological Activities of 3-(Cyclopentyloxy)-4-methoxybenzamides and Analogs
Journal of Medicinal Chemistry 1994.0
Novel, Potent, and Selective Phosphodiesterase-4 Inhibitors as Antiasthmatic Agents:  Synthesis and Biological Activities of a Series of 1-Pyridylnaphthalene Derivatives
Journal of Medicinal Chemistry 1999.0
Identification of 2,3-disubstituted pyridines as potent, orally active PDE4 inhibitors
Bioorganic & Medicinal Chemistry 2013.0
Identification of 2,3-disubstituted pyridines as potent, non-emetic PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2014.0
Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthma
Bioorganic & Medicinal Chemistry Letters 1998.0
Palladium-Catalyzed Cross-Coupling Reactions for the Synthesis of 6,8-Disubstituted 1,7-Naphthyridines:  A Novel Class of Potent and Selective Phosphodiesterase Type 4D Inhibitors
Journal of Medicinal Chemistry 2000.0
Design, synthesis and in vitro PDE4 inhibition activity of certain quinazolinone derivatives for treatment of asthma
Medicinal Chemistry Research 2012.0
New bronchodilators. 3. Imidazo[4,5-c][1,8]naphthyridin-4(5H)-ones
Journal of Medicinal Chemistry 1992.0
Novel Heterocyclic-Fused Pyridazinones as Potent and Selective Phosphodiesterase IV Inhibitors
Journal of Medicinal Chemistry 1997.0